Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicines and Healthcare products Regulatory Agency moves to strengthen regulatory policy roles with new director:

This article was originally published in Clinica

Executive Summary

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has installed a director of policy, in a new role which replaces that of the director of executive support. Shaun Gallagher will also be responsible for links with the rest of government. As former head of industry policy at the DoH, managing the government's relationship with the pharmaceutical and healthcare industries, Mr Gallagher has experience of working with both the devices and pharmaceutical sectors and other healthcare industry stakeholders. The outgoing director of executive support was Roy Alder, who has now retired.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056968

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel